1'758 companies found
Alloy Therapeutics (Switzerland) AG
Allschwil · Since 2019
Alnylam Switzerland GmbH
Zug · Since 2015
The company is a pharmaceutical or biotechnology company specializing in the development and manufacture of medicines for rare diseases. The core activity includes research and development of RNAi-based therapies, the manufacture and marketing of medicines, as well as the provision of patient services, including genetic counseling and patient advocacy.
AMAZENTIS SA
Lausanne · Since 2007
AMAZENTIS SA develops clinically studied nutritional ingredients and consumer health products targeting cellular and mitochondrial health and age-related declines in muscle function. The company markets its proprietary ingredient Mitopure through the Timeline® consumer brand and lists Nestlé Health Science as a global strategic partner.
Amigard GmbH
Zollikon · Since 2017
The core activity of Amigard GmbH is the distribution of antiparasitic products for pets, particularly for dogs, cats and horses, through an online shop.
Amphilix AG
Bettingen · Since 2020
ANTI AGING SERVICES Sàrl
Lonay · Since 2010
Ashland Industries Europe GmbH
Schaffhausen · Since 2005
Ashland is a specialty chemicals company that offers a wide range of products and solutions for various industries, including: Life Sciences: pharmaceuticals, medical devices, dietary supplements, and personal care products; Personal Care: hair care, oral care, skin care, and household products; Specialty Additives: chemicals and additives for various applications, such as paints, coatings, adhesives, textiles, and electronics; Intermediates: chemical intermediates for the production of other products; and Crop Care: crop protection products and plant growth regulators. The company develops and manufactures innovative solutions to enhance the integrity and profitability of customers' products and applications, with a focus on sustainability and responsible business practices.
Atheris SA
Plan-Les-Ouates · Since 2012
Atnahs Pharma Switzerland AG
Zug · Since 2021
The core activity of Pharmanovia is the development, manufacture, marketing and distribution of pharmaceuticals, particularly established branded medicines, as well as the rediscovery and repositioning of existing medicines. This also includes the acquisition and licensing of supportive therapies, the conduct of clinical trials and the management of approval procedures.
AVEA LIFE AG
Zug · Since 2021
Avea develops and manufactures dietary supplements based on scientific research and cutting-edge technology, with the goal of supporting human health and well-being.
Axanton Technology GmbH
Schlieren · Since 2013
Axanton Technology GmbH develops MEMS (Molecules Establishing Membrane Signaling), a technology for producing therapeutic biomolecules that target chemically modified membrane protein sequences to restore membrane protein homeostasis. The company conducts research and preclinical development of candidates such as A‑144 and holds patented technology for MEMS production.
Bayer Consumer Care AG
Basel · Since 2005
Bayer (Schweiz) AG
Zurich · Since 1954
BE-CEUTICALS SA
Conthey · Since 2013
The core activity of Be Ceuticals is the development, manufacture and distribution of dermal fillers and skinbooster serums, in particular based on hyaluronic acid, for skin rejuvenation and care.
Beijing Tong Ren Tang Swiss SA
Geneva · Since 2017
Belimed AG, Zweigniederlassung Sulgen
Sulgen · Since 2016
Belimed AG, Zweigniederlassung Sulgen designs and supplies automated process solutions for cleaning and sterilization for the pharmaceutical, biopharmaceutical, laboratory and cosmetics sectors. Offerings include cGMP‑compliant cleaning systems, sterilizers, racks and accessories, together with lifecycle services such as qualification, maintenance, retrofit and remote support.
Bio API SA
Lugano · Since 2010
Biocon Biologics Switzerland AG
Zurich · Since 2023
Biocon Biologics Switzerland AG is a biosimilars company active in the development, manufacturing and commercialization of biologic therapies. Its portfolio includes insulins, monoclonal antibodies and conjugated recombinant proteins for indications such as diabetes, cancer, autoimmune diseases and serious eye conditions.
BioCryst Schweiz GmbH
Zug · Since 2021
The core activity of BioCryst is the development and commercialization of medicines for rare diseases, particularly hereditary angioedema (HAE) and other rare disorders. The company focuses on the development of oral small molecules and protein therapeutics based on a combination of traditional biology, medicinal chemistry, and advanced technologies.
Biodevelop AG
Hergiswil Nw · Since 2008
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register